The EMIT® II Plus 6-Acetylmorphine Assay accurately detects heroin use, without cross-reactivity to morphine, morphine metabolites, and many common analgesics.
The Emit® II Plus Oxycodone Assay is used for the determination of oxycodone and its metabolite, oxymorphone, in human urine.
The EMIT® II Plus Amphetamines Assay is intended for the qualitative and semiquantitative determination of amphetamines in human urine.
The EMIT® II Plus Barbiturate Assay is intended for the qualitative and semiquantitative analysis of barbiturates in human urine at a cutoff value of 200 ng/mL or 300 ng/mL.
The EMIT® II Plus Benzodiazepine Assay is intended for the qualitative and semiquantitative analysis of benzodiazepine and benzodiazepine metabolites in human urine at a cutoff value of 200 ng/mL or 300 ng/mL.
The EMIT® II Plus Buprenorphine Assay is intended for the qualitative and semiquantitative analysis of buprenorphine in human urine at a cutoff value of 5 ng/mL.
The EMIT® II Plus Cannabinoid Assay is intended for the qualitative and semiquantitative analysis of cannabinoids in human urine at a cutoff value of 20 ng/mL, 50 ng/mL, or 100 ng/mL. The SAMHSA initial test cutoff level is 50 ng/mL.
The EMIT® II Plus Cocaine Metabolite Assay is intended for the qualitative and semiquantitative determination of benzoylecgonine in human urine, at a cutoff value of 150 ng/mL or 300 ng/mL. The SAMHSA initial test cutoff level is 150 ng/mL.
The EMIT® II Plus Ecstasy Assay is intended for the qualitative and semiquantitative analysis of methylenedioxymethamphetamine (MDMA) and closely related drugs in human urine at a cutoff value of 300 ng/mL or 500 ng/mL. The SAMHSA initial test cutoff level is 500 ng/mL.
The EMIT® II Plus Ethyl Alcohol Assay has been designed to accurately quantitate ethyl alcohol in urine, serum, and plasma.
The EMIT II LSD Assay is intended for the qualitative and semiquantitative determination of lysergic acid diethylamide in human urine at a cutoff level of 0.5 ng/mL.
The EMIT® II Plus Methadone Assay is intended for the qualitative and semiquantitative determination of methadone in human urine at a cutoff level of 150 ng/mL or 300 ng/mL.
The EMIT® II Plus Methaqualone Assay is intended for the qualitative and semiquantitative analysis of methaqualone in human urine at a cutoff level of 300 ng/mL.
The EMIT® II Plus Opiate Assay is intended for the qualitative and semiquantitative analysis of opiates in human urine at a cutoff value of 300 ng/mL or 2000 ng/mL. The SAMHSA initial test cutoff level is 2000 ng/mL.
The EMIT® II Plus Phencyclidine Assay is intended for the qualitative and semiquantitative analysis of phencyclidine in human urine at a cutoff value of 25 ng/mL. The SAMHSA initial test cutoff level is 25 ng/mL.
The EMIT® II Plus Propoxyphene Assay is intended for the qualitative and semiquantitative analyses of propoxyphene in human urine at a cutoff level of 300 ng/mL.
